|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
91-92
|
|
pubmed:dateCreated |
2009-7-22
|
|
pubmed:abstractText |
A cell-mediated immunodeficiency is demonstrated to occur in advanced cancer patients. Lymphocytopenia predicts a poor prognosis, moreover, the surgical trauma can worsen the impaired immune surveillance and favor disease recurrence. This study investigates the effectiveness of preoperative interleukin-2 administration to improve lymphocyte counts' postoperative recovery in pancreatic cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0172-6390
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
861-5
|
|
pubmed:meshHeading |
pubmed-meshheading:19621718-Adult,
pubmed-meshheading:19621718-Aged,
pubmed-meshheading:19621718-Aged, 80 and over,
pubmed-meshheading:19621718-Antineoplastic Agents,
pubmed-meshheading:19621718-Carcinoma, Pancreatic Ductal,
pubmed-meshheading:19621718-Drug Administration Schedule,
pubmed-meshheading:19621718-Female,
pubmed-meshheading:19621718-Humans,
pubmed-meshheading:19621718-Interleukin-2,
pubmed-meshheading:19621718-Lymphocyte Count,
pubmed-meshheading:19621718-Male,
pubmed-meshheading:19621718-Middle Aged,
pubmed-meshheading:19621718-Neoadjuvant Therapy,
pubmed-meshheading:19621718-Pancreatic Neoplasms,
pubmed-meshheading:19621718-Pancreaticoduodenectomy,
pubmed-meshheading:19621718-Recombinant Proteins
|
|
pubmed:articleTitle |
Short-term preoperative IL-2 immunotherapy in operable pancreatic cancer: a randomized study.
|
|
pubmed:affiliation |
Department of Surgery, San Gerardo Hospital, University of Milan-Bicocca, Monza, Italy.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
